Published in Blood on October 01, 2001
Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature (2010) 5.02
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood (2010) 4.46
Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood (2011) 3.02
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A (2011) 2.96
How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood (2009) 2.86
Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev (2009) 2.75
The ageing immune system: is it ever too old to become young again? Nat Rev Immunol (2009) 2.48
CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood (2013) 2.22
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med (2004) 1.84
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood (2003) 1.79
Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PLoS One (2011) 1.62
Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol (2008) 1.61
Impact of donor age on outcome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2014) 1.59
A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood (2012) 1.53
High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients. Biol Blood Marrow Transplant (2014) 1.47
Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol Oncol Clin North Am (2011) 1.42
DNA repair is crucial for maintaining hematopoietic stem cell function. DNA Repair (Amst) (2008) 1.40
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood (2009) 1.40
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood (2007) 1.36
Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy. Biol Blood Marrow Transplant (2009) 1.35
T cell replicative senescence in human aging. Curr Pharm Des (2013) 1.31
Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? Blood (2013) 1.27
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults. J Clin Oncol (2015) 1.25
Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials. J Acquir Immune Defic Syndr (2010) 1.24
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant (2014) 1.23
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood (2012) 1.22
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2010) 1.22
Age-associated declines in immune system development and function: causes, consequences, and reversal. Curr Opin Immunol (2009) 1.16
Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients. Blood (2009) 1.14
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood (2015) 1.09
Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection? Aging (Albany NY) (2011) 1.04
HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. Blood (2007) 1.00
Aging and inflammation: etiological culprits of cancer. Curr Aging Sci (2009) 0.97
Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG). J Hematol Oncol (2014) 0.97
Clinical impact of H-Y alloimmunity. Immunol Res (2014) 0.96
Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin North Am (2010) 0.94
Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients. Biol Blood Marrow Transplant (2012) 0.93
Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity. Blood (2006) 0.93
Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors. Haematologica (2013) 0.93
ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation. Transfus Med Hemother (2015) 0.93
Stress and stem cells. Wiley Interdiscip Rev Dev Biol (2012) 0.93
Telomeres, atherosclerosis, and the hemothelium: the longer view. Annu Rev Med (2011) 0.91
Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies. Biol Blood Marrow Transplant (2012) 0.91
Concise review: hematopoietic stem cell aging, life span, and transplantation. Stem Cells Transl Med (2012) 0.89
Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplant. Leuk Lymphoma (2013) 0.88
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. Biol Blood Marrow Transplant (2011) 0.87
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning. J Clin Oncol (2015) 0.87
Aging, Clonality, and Rejuvenation of Hematopoietic Stem Cells. Trends Mol Med (2016) 0.86
Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation. Bone Marrow Transplant (2014) 0.85
Getting to the Heart of Being the Match: A Qualitative Analysis of Bone Marrow Donor Recruitment and Retention Among College Students. Health Educ (Muncie) (2014) 0.85
Which donor or graft source should you choose for the strongest GVL? Is there really any difference. Best Pract Res Clin Haematol (2013) 0.84
Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus. Am J Pathol (2011) 0.84
Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancy. Am J Reprod Immunol (2013) 0.84
Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period. Am J Reprod Immunol (2014) 0.83
Cytomegalovirus pneumonia in hematopoietic stem cell recipients. J Intensive Care Med (2013) 0.83
Donor-recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation. Eye (Lond) (2011) 0.82
H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male : female ratio in subsequent live births. Hum Reprod (2010) 0.82
Risk assessment before allogeneic hematopoietic cell transplantation for older adults with acute myeloid leukemia. Expert Rev Hematol (2013) 0.82
What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation? Best Pract Res Clin Haematol (2008) 0.81
Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy. Haematologica (2015) 0.81
Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation. Front Immunol (2016) 0.80
Haematopoietic stem and progenitor cells in rheumatoid arthritis. Rheumatology (Oxford) (2010) 0.80
Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant. Haematologica (2012) 0.80
Human and Murine Hematopoietic Stem Cell Aging Is Associated with Functional Impairments and Intrinsic Megakaryocytic/Erythroid Bias. PLoS One (2016) 0.78
Concise review: hematopoietic stem cell aging and the prospects for rejuvenation. Stem Cells Transl Med (2014) 0.78
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation. Am J Hematol (2016) 0.78
Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments. Front Immunol (2016) 0.78
Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT. Bone Marrow Transplant (2015) 0.78
Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant (2016) 0.78
Modeling human hematopoietic stem cell biology in the mouse. Semin Hematol (2013) 0.77
Nonmyeloablative allogeneic hematopoietic cell transplantation. Haematologica (2016) 0.76
Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities. World J Stem Cells (2016) 0.76
A simple model system enabling human CD34(+) cells to undertake differentiation towards T cells. PLoS One (2013) 0.76
Kidney transplantation and the ageing immune system. Nat Rev Nephrol (2012) 0.76
Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes. Haematologica (2015) 0.75
Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation. Biol Blood Marrow Transplant (2013) 0.75
BONE MARROW, THYMUS AND BLOOD: CHANGES ACROSS THE LIFESPAN. Aging health (2009) 0.75
Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031. Bone Marrow Transplant (2010) 0.75
Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia. Biol Blood Marrow Transplant (2016) 0.75
Donor parity no longer a barrier for female-to-male hematopoietic stem cell transplantation. Chimerism (2014) 0.75
A review of the haematopoietic stem cell donation experience: is there room for improvement? Bone Marrow Transplant (2014) 0.75
Effect of blood donor characteristics on transfusion outcomes: a protocol for systematic review and meta-analysis. Syst Rev (2014) 0.75
Low immunosuppressive burden after HLA-matched related or unrelated BMT using post-transplantation cyclophosphamide. Blood (2017) 0.75
Unraveling the Gordian knot: red blood cell storage lesion and transfusion outcomes. Blood Transfus (2017) 0.75
Structural investigation of donor age effect on human bone marrow mesenchymal stem cells: FTIR spectroscopy and imaging. Age (Dordr) (2014) 0.75
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas. Bone Marrow Transplant (2016) 0.75
Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer. PLoS One (2012) 0.75
Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignancies. World J Stem Cells (2014) 0.75
Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease. Biol Blood Marrow Transplant (2016) 0.75
Selecting donor recipients. Biol Blood Marrow Transplant (2009) 0.75
CMV in Hematopoietic Stem Cell Transplantation. Mediterr J Hematol Infect Dis (2016) 0.75
The aging hematopoietic stem cell niche: Phenotypic and functional changes and mechanisms that contribute to hematopoietic aging. Semin Hematol (2016) 0.75
Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia. Haematologica (2016) 0.75
Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity? Croat Med J (2016) 0.75
Precision in donor selection: Identifying ideal stem-cell donors through their T cells. Exp Hematol (2016) 0.75
Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation. Immunogenetics (2013) 0.75
How Do Donor-Recipient CMV Serostatus and Post-Hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients? Int J Hematol Oncol Stem Cell Res (2017) 0.75
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell (1993) 6.83
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med (1999) 5.82
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol (1997) 4.51
Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science (1982) 4.10
Occupation, education, and coronary heart disease. Risk is influenced more by education and background than by occupational experiences, in the Bell System. Science (1968) 4.07
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med (2001) 3.98
Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood (2000) 3.85
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med (1992) 3.77
Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet (2002) 3.61
Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol (1991) 3.21
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood (1998) 3.06
Couple communication, sexual coercion and HIV risk reduction in Kigali, Rwanda. AIDS (1995) 2.97
Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant (2010) 2.87
The genetic heritage of the earliest settlers persists both in Indian tribal and caste populations. Am J Hum Genet (2003) 2.82
ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science (1994) 2.71
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med (1993) 2.71
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol (2001) 2.69
Sensor positioning for activity recognition using wearable accelerometers. IEEE Trans Biomed Circuits Syst (2011) 2.68
Cat scratch disease: posterior segment manifestations. Ophthalmology (1999) 2.67
Long-term changes in intraocular pressure after clear corneal phacoemulsification: normal patients versus glaucoma suspect and glaucoma patients. J Cataract Refract Surg (1999) 2.63
HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol (1997) 2.59
Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. Science (1983) 2.48
Psychopathology associated with suicidal ideation and attempts among children and adolescents. J Am Acad Child Adolesc Psychiatry (1998) 2.46
Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet (1995) 2.40
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med (1998) 2.36
ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion (1999) 2.35
Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant (2006) 2.32
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood (1990) 2.32
Improved survival for patients with acute myelogenous leukemia. J Clin Oncol (1995) 2.30
Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield. Transfusion (1997) 2.17
A regional register of early childhood impairments: a discussion paper. The Steering Committee of the Oxford Region Child Development Project. Community Med (1989) 2.14
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood (1992) 2.14
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood (1990) 2.09
Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology (2007) 2.05
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant (2013) 2.04
Carcinoma of the gallbladder: staging, treatment, and prognosis. Cancer (1976) 2.02
The histocompatibility system in juvenile, insulin-dependent diabetic multiplex kindreds. J Clin Invest (1977) 2.01
Epidemiology of cerebral palsy in England and Scotland, 1984-9. Arch Dis Child Fetal Neonatal Ed (1998) 2.01
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant (2001) 2.00
The successful recruitment of elderly black subjects in a clinical trial: the CRISP experience. Cholesterol Reduction in Seniors Program. J Natl Med Assoc (1995) 1.99
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol (2000) 1.92
Linkage analysis between the major histocompatibility system and insulin-dependent diabetes in families with patients in two consecutive generations. J Clin Invest (1980) 1.90
Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother (1998) 1.82
Estrogen and progesterone receptors: correlation of response rates, site and timing of receptor analysis. Breast Cancer Res Treat (1982) 1.81
Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet (2004) 1.80
Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol (2001) 1.79
Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Bone Marrow Transplant (2010) 1.68
Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med (1992) 1.68
Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med (1989) 1.67
Audit suggests that use of aspirin is rising in coronary heart disease. BMJ (1995) 1.67
Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood (1997) 1.65
Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr (1998) 1.65
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood (1997) 1.64
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors. J Clin Oncol (1996) 1.64
Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev (1994) 1.63
MRI-guided gas bubble enhanced ultrasound heating in in vivo rabbit thigh. Phys Med Biol (2003) 1.62
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood (1991) 1.61
ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion (2000) 1.61
Evaluating herbal medicine for the management of Herpes zoster in human immunodeficiency virus-infected patients in Kampala, Uganda. J Altern Complement Med (1999) 1.60
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood (1986) 1.60
Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med (1994) 1.60
Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors. AIDS Res Hum Retroviruses (1995) 1.59
Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer. J Exp Med (1987) 1.57
Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia (2006) 1.57
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood (1994) 1.57
Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol (1995) 1.57
Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med (1988) 1.56
Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol (1991) 1.55
The contribution of low birth weight to severe vision loss in a geographically defined population. Br J Ophthalmol (1998) 1.54
Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant (2006) 1.53
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood (1989) 1.52
Classification of pressure ulcers. Arch Dermatol (1990) 1.48
A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease. Biol Blood Marrow Transplant (2000) 1.48
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant (1995) 1.47
Modeling of carbon fiber couch attenuation properties with a commercial treatment planning system. Med Phys (2008) 1.47
Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. Bone Marrow Transplant (2008) 1.46
Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol (1986) 1.46
Marrow transplantation from unrelated donors. Curr Opin Hematol (1995) 1.45
A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified. J Am Acad Child Adolesc Psychiatry (1996) 1.45
Obtaining parental consent--opting in or opting out? Arch Dis Child (1985) 1.45
Etomidate use during emergency intubation of trauma patients. Am J Emerg Med (1997) 1.45